newsfilter
← Latest News
GlobeNewswire·

ProQR Announces Second Quarter 2025 Operating and Financial Results

Submitted CTA for lead program AX-0810, targeting NTCP for cholestatic diseasesAdvancing AX-2402 program toward clinical candidate selection, targeting MECP2 (R270X) for Rett SyndromeHosting fall Analyst and Investor